Published on:

Packaging Defects Prompts Pharmaceutical Recall of Anti-Psychotic Drug

Olanzapine, a common anti-psychotic drug used to treat illnesses such as schizophrenia and bipolar disorder, has been recalled by its manufacturer in light of major defects in the drug’s packaging. Reports indicate that the United States Food and Drug Administration requested that the pharmaceutical manufacturer, Torrent Pharmaceuticals Ltd, recall their recent output of Olanzapine 10 mg tablets as a “precautionary measure” due to the fact that the drug is repackaged in the United States upon delivery from India. It is reported that upon repackaging of the drug in the United States, the filler material that is currently being used removes or blocks less moisture that was is approved under the FDA guidelines.

Reports from EconomicTimes.com indicate that this particular recall has been classified by the FDA as a Class II – or one that implies that use of or exposure to the defective product may lead to temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. Although this pharmaceutical recall may not lead to devastating consequences for those individuals who are prescribed Olanzapine, this is not the first time the pharmaceutical manufacturer Torrent has been in trouble with the FDA.

In early 2012, the FDA refused the importation of Torrent’s new product, Aripiprazole 5 mg tablets. Aripiprazole – a drug that has been classified by EvaluateGroup.com as a “new generation of dopamine system stabilizers, the first in a new class of antipsychotics and a major therapeutic advancement in the management of schizophrenia” was charged with numerous violations upon importation into the United States from India. The Food and Drug Administration charged Torrent with numerous violations cited under their Misbranding and Unapproved New Drug sections. Later that year, Torrent incurred a second import refusal for their drug Lamotrigine for violating the same sections.

Any Chicago injury attorney will tell you that when faulty or defective products, such as pharmaceuticals, are manufactured, sold, and ultimately consumed the public – the chances of tragic or life-altering consequences dramatically increase. Despite the implementation of numerous governmental agencies that are designed to deter or stop the output of harmful and dangerous pharmaceuticals, such as the Food and Drug Administration, it is estimated that at least 1.5 million pharmaceutical related injuries occur each and every year – according to DrugWatch.com

These types of cases involving product liability are often extremely complex and may require experienced legal counsel. Our Illinois injury lawyers at Levin & Perconti have skillfully handled a wide variety of product liability cases and have obtained successful verdicts and settlements on behalf of our clients and their families. Not only that – lawsuits raise awareness surrounding defective products and medications and help to ensure that these unsafe and defective products are removed from public consumption and prevented from causing any future harm and/or damage to consumers.

If you or a loved one has sustained harm or even death as a direct result of defective pharmaceuticals, please contact our attorneys for a free consultation to see what legal rights may be available to you.